Neuroimaging Biomarkers for Alzheimer's Disease

Neuroimaging Biomarkers for Alzheimer's Disease

Product not yet rated

This presentation explores the role of neuroimaging biomarkers in the early detection and diagnosis of Alzheimer's disease. We discuss advanced imaging techniques such as PET-CT, MRI, and amyloid imaging, and their utility in identifying preclinical and prodromal stages of Alzheimer's disease.

Key:

Complete
Failed
Available
Locked
Recorded Video
Open to view video.
Open to view video.
Evaluation
8 Questions
8 Questions Thank you for participating in Neuroimaging Biomarkers for Alzheimer's Disease. Your feedback is valuable and will help us improve future programs. Please take a few minutes to answer the following questions.